针对……和……的治疗策略 。 你提供的原文不太完整，“against”后面应该还有具体的内容。
Therapeutic Strategies against and .
作者信息
Santos André L S, Rodrigues Igor A, d'Avila-Levy Claudia M, Sodré Cátia L, Ritmeijer Koert, Branquinha Marta H
机构信息
Laboratório de Estudos Avançados de Microrganismos Emergentes e Resistentes (LEAMER), Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil.
Departamento de Produtos Naturais e Alimentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil.
出版信息
Pathogens. 2023 Oct 19;12(10):1263. doi: 10.3390/pathogens12101263.
Abstract
Human African trypanosomiasis (also known as sleeping sickness, with and as etiological agents), American trypanosomiasis (also known as Chagas disease, with as the etiological agent), and leishmaniasis (including cutaneous, mucocutaneous, and visceral forms, with multiple species belonging to the genus as etiological agents) are recognized as neglected tropical diseases (NTDs) [...].
摘要
人类非洲锥虫病（也称为昏睡病，病原体为布氏冈比亚锥虫和布氏罗得西亚锥虫）、美洲锥虫病（也称为恰加斯病，病原体为克氏锥虫）和利什曼病（包括皮肤型、黏膜皮肤型和内脏型，病原体为利什曼原虫属的多个物种）被公认为是被忽视的热带病（NTDs）[...]。
相似文献
1
Therapeutic Strategies against and .针对……和……的治疗策略 。
你提供的原文不太完整，“against”后面应该还有具体的内容。
Pathogens. 2023 Oct 19;12(10):1263. doi: 10.3390/pathogens12101263.
2
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶（CYP51）的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
3
Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure.人类致病性锥虫的生物学：流行病学、生命周期与超微结构
Subcell Biochem. 2014;74:1-42. doi: 10.1007/978-94-007-7305-9_1.
4
The Production of Rhodesiense, Cause of African Sleeping Sickness, and , Cause of American Chagas Disease, on Different Medias and Testing a New Media.罗德西亚锥虫（非洲昏睡病的病原体）和克氏锥虫（美洲恰加斯病的病原体）在不同培养基上的培养以及对一种新培养基的测试
Turkiye Parazitol Derg. 2020 Mar 20;44(1):7-11. doi: 10.4274/tpd.galenos.2019.6656.
5
Determinants of disease phenotype in trypanosomatid parasites.锥虫原生动物寄生虫疾病表型的决定因素。
Trends Parasitol. 2014 Jul;30(7):342-9. doi: 10.1016/j.pt.2014.05.001. Epub 2014 Jun 16.
6
Priorities for the elimination of sleeping sickness.消灭昏睡病的重点。
Adv Parasitol. 2012;79:299-337. doi: 10.1016/B978-0-12-398457-9.00004-4.
7
Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.DB829 的药代动力学、冈比亚锥虫疗效和药物作用时间，一种用于治疗第二期人类非洲锥虫病的临床前候选药物。
Antimicrob Agents Chemother. 2013 Nov;57(11):5330-43. doi: 10.1128/AAC.00398-13. Epub 2013 Aug 19.
8
3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.3-(恶唑并[4,5-b]吡啶-2-基)苯胺类作为新型有效的克氏锥虫抑制剂，克氏锥虫是引起人类非洲锥虫病的病原体。
Eur J Med Chem. 2013 Aug;66:450-65. doi: 10.1016/j.ejmech.2013.05.007. Epub 2013 May 16.
9
Conventional therapy and promising plant-derived compounds against trypanosomatid parasites.针对锥虫寄生虫的传统疗法及有前景的植物源化合物
Front Microbiol. 2012 Aug 6;3:283. doi: 10.3389/fmicb.2012.00283. eCollection 2012.
10
Ornithine decarboxylase and S-adenosylmethionine decarboxylase in trypanosomatids.锥虫中的鸟氨酸脱羧酶和S-腺苷甲硫氨酸脱羧酶。
Biochem Soc Trans. 2007 Apr;35(Pt 2):314-7. doi: 10.1042/BST0350314.
引用本文的文献
1
Multi-target Compounds against Trypanosomatid Parasites and .抗寄生原生物多靶标化合物及...
Curr Drug Targets. 2024;25(9):602-619. doi: 10.2174/0113894501306843240606114854.
本文引用的文献
1
Communication in Neglected Tropical Diseases' elimination: A scoping review and call for action.被忽视热带病消除中的沟通：范围综述和行动呼吁。
PLoS Negl Trop Dis. 2022 Oct 13;16(10):e0009774. doi: 10.1371/journal.pntd.0009774. eCollection 2022 Oct.
2
The Natural Alkaloid Tryptanthrin Induces Apoptosis-like Death in spp.天然生物碱靛玉红诱导[物种名称未给出]细胞发生凋亡样死亡
Trop Med Infect Dis. 2022 Jun 20;7(6):112. doi: 10.3390/tropicalmed7060112.
3
Approaches to advance drug discovery for neglected tropical diseases.推进被忽视热带病药物研发的方法。
Drug Discov Today. 2022 Aug;27(8):2278-2287. doi: 10.1016/j.drudis.2022.04.004. Epub 2022 Apr 7.
4
Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by Infection.口服呋喃妥因对感染所致动物非洲锥虫病的治疗效果
Pathogens. 2022 Mar 9;11(3):331. doi: 10.3390/pathogens11030331.
5
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B.钙蛋白酶抑制剂MDL28170与两性霉素B联合使用的抗利什曼原虫疗效。
Trop Med Infect Dis. 2022 Feb 16;7(2):29. doi: 10.3390/tropicalmed7020029.
6
Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B.脂质体两性霉素B治疗复杂性皮肤利什曼病
Pathogens. 2021 Sep 28;10(10):1253. doi: 10.3390/pathogens10101253.
7
Beating Neglected Tropical Diseases: For Good and For All.战胜被忽视的热带病：一劳永逸
China CDC Wkly. 2020 Feb 7;2(6):92-93.
8
Scoping review of Neglected Tropical Disease Interventions and Health Promotion: A framework for successful NTD interventions as evidenced by the literature.忽视热带病干预措施和健康促进的范围审查：文献证据表明成功的忽视热带病干预措施的框架。
PLoS Negl Trop Dis. 2021 Jul 6;15(7):e0009278. doi: 10.1371/journal.pntd.0009278. eCollection 2021 Jul.
9
The impact of climate change on neglected tropical diseases: a systematic review.气候变化对被忽视热带病的影响：系统评价。
Trans R Soc Trop Med Hyg. 2021 Jan 28;115(2):147-168. doi: 10.1093/trstmh/traa192.
10
One Health and Neglected Tropical Diseases-Multisectoral Solutions to Endemic Challenges.同一健康与被忽视的热带病——应对地方病挑战的多部门解决方案。
Trop Med Infect Dis. 2020 Dec 29;6(1):4. doi: 10.3390/tropicalmed6010004.
Zotero 插件